Literature DB >> 3034744

Effect of oxytetracycline administration on intestinal metabolism of oestrogens and on plasma sex hormones in healthy men.

E Hämäläinen, J T Korpela, H Adlercreutz.   

Abstract

The effect of oxytetracycline (1 g/day for five days) on the enterohepatic recycling of oestrogens and on plasma sex hormone concentrations was assessed in healthy men. Plasma oestrone (E1), oestradiol-17 beta (E2), 4-androstenedione (A), 5 alpha-dihydrotestosterone (5 alpha-DHT), total and free testosterone (T and free T), binding capacity of sex hormone binding globulin, luteinizing hormone, dehydroepiandrosterone-sulphate, urinary total E1, E2, and oestriol (E3), and oestriol-3-glucuronide (E3-3G) and faecal unconjugated and conjugated E1, E2, and E3 were measured by radioimmunoassay (RIA). Treatment with the antibiotic significantly increased the excretion of faecal conjugated oestrogens, which parallelled a decrease in urinary oestrogen excretion, especially of E3. The effect on urinary E3 could be explained almost entirely by the simultaneous decrease of urinary E3-3G concentrations. In urine and faeces the E2/E3 and E1 + E2/E3 ratios increased, probably because of the diminished reductive metabolism of oestrogens in the gut. No significant effects on plasma unconjugated oestrogen concentrations were observed. Moreover, in the present study oxytetracycline had no remarkable effect on plasma total, or free T concentrations, nor on other plasma hormones measured. Our results suggest that enterohepatic recycling and intestinal metabolism of oestrogens may be significant in men. The mechanism of action of antibiotics on oestrogen metabolism probably involves decreased hydrolysis by beta-glucuronidase of oestrogen conjugates by the intestinal contents, diminishing the reabsorption of aglycones of oestrogen conjugates and resulting in faecal loss of the steroids.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3034744      PMCID: PMC1432818          DOI: 10.1136/gut.28.4.439

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  25 in total

1.  Effect of ampicillin treatment on the urinary excretion of estriol conjugates in pregnancy.

Authors:  M J Tikkanen; M O Pulkkinen; H Adlercreutz
Journal:  J Steroid Biochem       Date:  1973-07       Impact factor: 4.292

2.  Degradation of steroids by intestinal bacteria. IV. The aromatisation of ring A.

Authors:  P Goddard; M J Hill
Journal:  Biochim Biophys Acta       Date:  1972-10-05

3.  A simplified method for the quantitative determination of testosterone-estradiol-binding globulin activity in human plasma.

Authors:  W Rosner
Journal:  J Clin Endocrinol Metab       Date:  1972-06       Impact factor: 5.958

4.  Reduction of maternal estrogen excretion by neomycin.

Authors:  M O Pulkkinen; K Willman
Journal:  Am J Obstet Gynecol       Date:  1973-04-15       Impact factor: 8.661

5.  Comparison of the conjugated metabolites of intravenously and intraduodenally administered oestriol.

Authors:  K F Stoa; M Levitz
Journal:  Acta Endocrinol (Copenh)       Date:  1968-04

6.  Reduced maternal plasma and urinary estriol during ampicillin treatment.

Authors:  K Willman; M O Pulkkinen
Journal:  Am J Obstet Gynecol       Date:  1971-03-15       Impact factor: 8.661

7.  Androgen metabolism in the beagle: endogenous C19O2 metabolites in bile and faeces and the effect of ampicillin administration.

Authors:  F Martin; A S Bhargava; H Adlercreutz
Journal:  J Steroid Biochem       Date:  1977-07       Impact factor: 4.292

8.  Intestinal metabolism of estrogens.

Authors:  H Adlercreutz; F Martin; M Pulkkinen; H Dencker; U Rimér; N O Sjöberg; M J Tikkanen
Journal:  J Clin Endocrinol Metab       Date:  1976-09       Impact factor: 5.958

9.  Effect of ampicillin administration on plasma conjugated and unconjugated estrogen and progesterone levels in pregnancy.

Authors:  H Adlercreutz; F Martin; T Lehtinen; M J Tikkanen; M O Pulkkinen
Journal:  Am J Obstet Gynecol       Date:  1977-06-01       Impact factor: 8.661

10.  Comparison of the metabolism of oestriol-3-glucosiduronate and oestriol-16-glucosiduronate in pregnant women.

Authors:  U Goebelsmann; I Cooke; N Wiqvist; E Diczfalusy
Journal:  Acta Endocrinol (Copenh)       Date:  1966-05
View more
  4 in total

Review 1.  The Intestinal Microbiome and Estrogen Receptor-Positive Female Breast Cancer.

Authors:  Maryann Kwa; Claudia S Plottel; Martin J Blaser; Sylvia Adams
Journal:  J Natl Cancer Inst       Date:  2016-04-22       Impact factor: 13.506

Review 2.  Enteric Microbiota⁻Gut⁻Brain Axis from the Perspective of Nuclear Receptors.

Authors:  Kalina Duszka; Walter Wahli
Journal:  Int J Mol Sci       Date:  2018-07-28       Impact factor: 5.923

Review 3.  The Microbiome-Estrogen Connection and Breast Cancer Risk.

Authors:  Sheetal Parida; Dipali Sharma
Journal:  Cells       Date:  2019-12-15       Impact factor: 6.600

4.  No changes in levels of bone formation and resorption markers following a broad-spectrum antibiotic course.

Authors:  Kristian H Mikkelsen; Tina Vilsbøll; Jens J Holst; Bolette Hartmann; Filip K Knop; Morten Frost
Journal:  BMC Endocr Disord       Date:  2018-09-04       Impact factor: 2.763

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.